[213+ Pages Report] According to a market research study published by Facts and Factors, the demand analysis of Global Neuroscience Market size & share revenue is estimated to grow over USD 39.09 Million by 2028, at a CAGR of approximately 3.50% between 2022 and 2028. The market is predicted to be dominated by the rising incidence of brain-related illnesses and the number of developed healthcare systems.
NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Neuroscience Market Size, Share, Growth Analysis Report By Component Type (Instruments, Software, and Services), By End User (Hospitals, Diagnostics Laboratories, Research Institutes, and Academic Institutes), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” in its research database.
“According to the latest research study, the demand of global Neuroscience Market size & share in terms of revenue was valued at USD 31.80 million in 2021 and it is expected to surpass around USD 39.09 million mark by 2028, growing at a compound annual growth rate (CAGR) of approximately 3.50% during the forecast period 2022 to 2028.”
What is Neuroscience? How big is the Neuroscience Industry?
Numerous scientific fields, including language, computation, philosophy, psychology, and chemistry, are related to neuroscience. The neurotic system is studied from a cellular, operational, behavioral, molecular, evolutionary, and therapeutic perspective. Several technologies are available in the neuroscience market that is used to image the nervous system.
The neuroscience market is anticipated to expand over the forecast period due to the accuracy of the equipment used by neuroscientists. The segment uses a variety of methods, including neuro-microscopy and proteomic analysis.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/neuroscience-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
About 213+ Pages Research Report (Including Recent Research)
Provide detailed chapter-by-chapter guidance on Request
Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
Includes Tables and figures have been updated
The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Facts and Factors research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
SCarl ZEISS AG, Danaher Corporation (Leica Microsystems), GE Company, Siemens AG, Koninklijke Philips N.V., Toshiba Corporation, Hitachi Medical Corp., EsaoteSpA, HAAG-STREIT Group, Opto fine Instruments Pvt. Ltd., Synaptive Medical, Operating Microscopes, Pridex Medicare Pvt. Ltd., and Others
By Component Type, End User, and Region
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Request customized purchase options to meet your research needs. Explore purchase options
Rising demand for neuroimaging technology for neuro-related diseases
Neuroscience relies heavily on proteomic technologies, which are in high demand due to their accessibility. The development of neuro-microscopy is aided by technological advances, fostering the expansion of the neuroscience market. Owing to technological advancement, the market is estimated to grow at a CAGR of 3.50% during the forecast period. The key reason driving the market expansion is the rising fatalities caused by various neurological disorders, including Parkinson's disease, Alzheimer's disease, schizophrenia, and other brain-related conditions.
Other significant growth-inducing elements include the rising demand for neuroimaging technologies and the ongoing research and investigation efforts into brain mapping. The governments of numerous countries are also making positive efforts to raise awareness about neurological illnesses and the available therapeutic choices. Additionally, the market is expanding due to the increased use of microscopy, optogenetics, magnetic resonance imaging (MRI), and electrophysiology tools in diagnosing various neurological illnesses.
However, the expensive cost of some instruments and ethical issues with animal testing is anticipated to impede market expansion.
Browse the full “Neuroscience Market Size, Share, Growth Analysis Report By Component Type (Instruments, Software, and Services), By End User (Hospitals, Diagnostics Laboratories, Research Institutes, and Academic Institutes), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/neuroscience-market
Neuroscience Market: COVID-19 Impact Analysis
Because of the COVID-19 outbreak, it is anticipated that all non-emergent brain imaging procedures and other procedures will be halted. This is anticipated to have a negative impact on the neuroscience business. There has been a flood of studies published to demonstrate how the pandemic has impacted the market that is the subject of the investigation. As a direct result of the epidemic, there is an increased sense of urgency throughout the majority of the world to strengthen mental health services. The COVID-19 pandemic has delayed clinical trial procedures, research and development, and pipeline products, all of which are expected to be affected, resulting in limited growth throughout the predicted time. This is due to the fact that there is a good late-stage product pipeline.
The Neuroscience Market is segregated based on component type and end users.
The market is divided into Instruments, Software, and Services based on component type. Compared to Software and services, the instrumentation segment generated a sizeable portion of sales. Nevertheless, this segment has a considerable market share due to its high pricing and availability of cutting-edge technology compared to other markets for neuroscience components.
Based on end users, the market is divided into Hospitals, Diagnostics Laboratories, Research Institutes, and Academic Institutes. Hospitals are expected to experience the fastest market growth in the predicted time frame. One of the key elements propelling the hospital segment is the growing desire of patients for hospitals to have a better diagnosis of their neurological problems. In addition, hospitals' high standard of care and the accessibility of cutting-edge technology has favorably influenced the segment's growth.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/neuroscience-market
Some of the main competitors dominating the global Neuroscience market include -
Opto fine Instruments Pvt. Ltd.
Key Insights from Primary Research:
As per the analysis shared by our research analyst, the Neuroscience market is estimated to grow annually at a CAGR of around 3.50% over the forecast period (2022-2028).
In Terms Of Revenue, The Neuroscience market size was valued at around USD 31.80 million in 2021 and is projected to reach USD 39.09 million by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
During the projected period, the diagnostic laboratories market segment is anticipated to dominate the worldwide neuroscience market.
Increase in Neuroscience research and funding. North America is expected to hold the largest market share over the forecast period.
Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/neuroscience-market
Key questions answered in this report:
What is the market size and growth rate forecast for Neuroscience industry?
What are the main driving factors propelling the Neuroscience Market forward?
What are the leading companies in the Neuroscience Industry?
What segments does the Neuroscience Market cover?
How can I receive a free copy of the Neuroscience Market sample report and company profiles?
Over the course of the forecast, North America is anticipated to hold the biggest market share. The increase in financing for various neurodegenerative disease research projects, the rise in disease prevalence and awareness, and the existence of significant market participants are the main drivers of market expansion in the investigated area. Key firms are concentrating on launching new items in the area to maintain their industry position.
Additionally, due to an increase in product launches, Asia Pacific is predicted to grow considerably. Thanks to its continuously expanding healthcare infrastructure and sizable target market, China and Japan are leading the charge in the same. Additionally, facilities for brain-related research are being expanded. For instance, the Mumbai, India-based artificial intelligence company Qure.ai recently unveiled new AI-driven technology that facilitates brain interpretation. The platform assists in using CT images to detect internal organ or tissue haemorrhages, fractures, and other serious anomalies in the head.
NeuroNexus Technologies introduced the NeuroNexus Summa Framework in February 2022. The solution was created for life science researchers and seasoned electrophysiologists who want to quickly integrate electrical signal readouts from biological cells and tissues into their research workflow.
With the launch of a new partnership in December 2021, the Brain Tumor Foundation can offer free brain scans to anyone in the country. Swoop, the first portable magnetic resonance imaging (MRI) system to receive FDA clearance, was developed by Hyperfine, Inc., a pioneering medical device company.
Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/neuroscience-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
The global Neuroscience market is segmented as follows:
The Middle East & Africa
Rest of the Middle East & Africa
Request For Free Sample Report of the Global Neuroscience Market @ https://www.fnfresearch.com/sample/neuroscience-market
Market Size & Forecast by Revenue | 2022−2028
Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
Market Segmentation – A detailed analysis by Component Type, End User, and Region
Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Browse Other Related Research Reports from Facts & Factors:
Global Cyber Security in Healthcare Market - https://www.fnfresearch.com/cyber-security-in-healthcare-market
Global Cryotherapy Units Market - https://www.fnfresearch.com/cryotherapy-units-market
Global Cell Culture Media Market - https://www.fnfresearch.com/cell-culture-media-market
Global Automated Cell Counters Market - https://www.fnfresearch.com/automated-cell-counters-market
Global Anaesthetic Equipment Market - https://www.fnfresearch.com/anaesthetic-equipment-market
Global Ankle Splint Market - https://www.fnfresearch.com/ankle-splint-market
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us on Twitter: https://twitter.com/fnfresearch
Follow Us on Facebook: https://www.facebook.com/factsandfactors/
Web: https://www.fnfresearch.com
Yahoo Finance Live anchors discuss stock performance for FedEx.
Mizuho analyst Vijay Rakesh just lowered his price target on Nvidia, but if he's right it's a good buy from here.
In this article, we discuss 10 high-yield dividend stocks for stable income. You can skip our detailed analysis of dividend stocks and their performance in the past, go directly and read 5 High-Yield Dividend Stocks for Stable Income. Dividend-paying stocks are gaining traction this year as investors look for cash during difficult times. Blue chip stable […]
There was a sell-off in cardboard packaging stocks this morning, with shares of International Paper (NYSE: IP) down 9.4% at 10:30 a.m. ET on Friday, Packaging Corporation of America (NYSE: PKG) shares down 9.7%, and the stock of WestRock (NYSE: WRK) down 9.8%. Shares of FedEx (NYSE: FDX) plunged more than 22% this morning after the company issued an earnings warning predicated on softening global volume. The volume FedEx referred to was the number of packages wrapped in cardboard and shipped to customers.
Today's video focuses on KLA (NASDAQ: KLAC), Lam Research (NASDAQ: LRCX), Applied Materials (NASDAQ: AMAT), and recent reports of upcoming regulations affecting these semiconductor companies. The video also discusses Intel's (NASDAQ: INTC) forthcoming data center solution and how it might not be as competitive as investors hoped.
Electric vehicle (EV) stocks have gotten a lot of attention over the last few years as production has increased and multiple companies have come public, but that doesn't mean all EV stocks are good investments. Companies still have to make money building and selling vehicles, which has historically been the hardest part of the auto business. Given the current trends, I think General Motors (NYSE: GM) is the one EV stock to buy hand over fist, while ChargePoint (NYSE: CHPT) and Canoo (NASDAQ: GOEV) have some serious red flags.
FedEx has blown three tires before the peak holiday shipping season, and chatter on the Street is that mighty Amazon may have played a role.
Struggling Bed Bath & Beyond Inc. releases a list of dozens of stores it aims to close. Most of the stores on this list will close by the end of the month.
Looking for high yield stocks in the finance sector? This pair of banks is worth close inspection, while this REIT is best avoided.
Long-time Real Money subscribers have come to learn I like to combine investment approaches. No one investment approach (fundamental, technical, quantitative) is perfect and better results can come from blending or combining different methods. The On-Balance-Volume (OBV) line has also moved sideways suggesting a balance between buyers and sellers.
Stéphane Bancel discusses the company’s latest Covid shot and prospects for using mRNA in seasonal flu vaccines and personalized treatments for cancer
While the latest federal moves on student loan forgiveness have some wrinkles, your journey to college debt clarity can still be smooth.
'He has gotten nowhere,' said West's lawyer about his attempts to work through partnership issues
Warren Buffett, Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) chief executive officer and chairman, has been investing since the age of 11. With his net worth at nearly $100 billion, the understatement of the century would be to say that Buffett knows a thing or two about investing. This is why it's worth paying attention to the holdings within Berkshire Hathaway's $344 billion investment portfolio.
Even the very profitable Tesla is getting incentives to help convert more Americans to electric vehicles.
Warren Buffett's Berkshire Hathaway is about to lose one of its higher-yielding dividend stocks. STORE Capital (NYSE: STOR), a real estate investment trust (REIT) with a high dividend yield, has agreed to be taken private by GIC and Oak Street. Because of that, Berkshire and other investors relying on STORE to supply them with passive income will need to find a replacement.
High-yield savings accounts are paying far higher rates than before, and some come with a cash bonus.
As bad the news was for FedEx, it may be worse news for the U.S. economy --- and an early sign of a recession.
You can't guess the bottom. But a bargain is a bargain.
Threadneedle Ventures Founder Ann Berry joins Yahoo Finance Live to discuss the FedEx warning, macroeconomic challenges, and the outlook for markets.